No Data
No Data
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX) and Boundless Bio Inc. (BOLD)
Express News | Boundless Bio : Sales Agreement Prospectus Covering Offering of up to $14.5 Million of Common Stock
Express News | Boundless Bio Inc Files for Mixed Shelf of up to $400 Mln – SEC Filing
Guggenheim Sticks to Its Hold Rating for Boundless Bio Inc. (BOLD)
Boundless Bio | 10-K: FY2024 Annual Report
73264095 : Nice, thanks! You think UMAC is done? looked like it held up pretty well in AH
Jaguar8 OP 73264095 : Nope. I feel it will still go
Jaguar8 OP 73264095 : I have not yet finished the list
Huaw : If APLT refuses to approve it, will it be
that many? this serious?
Jaguar8 OP Huaw : It was just a CRL meaning they can’t approve at the moment due to some deficiencies which the company will address and will resubmit
View more comments...